Profiting from innovations: the role of new game strategies in the case of Lipitor of the US pharmaceutical industry

$48.00 plus tax (Refund Policy)

Download / Buy Article:

Abstract:

In exploring why innovators often do not profit from their innovations, researchers concentrate on innovators versus imitators and the extent to which owners of complementary assets capture profits from innovations. The literature provides scant attention to factors that sap profits from innovations. This paper argues that an innovator's positioning vis-à-vis customers, suppliers, complementors, and other co-opetitors plays a critical role in the innovator's profitability. The article explores how an innovator can use new game strategies to better positioning, thus capturing rents from innovations and enabling further innovations in the future. The study examines the case of Lipitor, one of the world's best-selling drug, to illustrate how positioning can play in a firm's ability to profit from its innovations.

Document Type: Research Article

DOI: http://dx.doi.org/10.1111/j.1467-9310.2010.00597.x

Affiliations: 1: Seoul National University, 599 Gwanangno, Gwanak-gu, Seoul 151-742, South Korea., Email: profkang@snu.ac.kr 2: Michigan University, Steven S. Ross School of Business, 701 Tappan St. Ann Arbor, Michigan 48109, USA., Email: afuah@umich.edu

Publication date: March 1, 2010

Related content

Tools

Favourites

Share Content

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
X
Cookie Policy
ingentaconnect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more